OrthoAccel Technologies
Houston
About OrthoAccel Technologies
OrthoAccel Technologies (OATI) designs, develops, markets, and sells the most revolutionary device in orthodontics – the Celerect 1000 – that cuts treatment time for braces in half and works in combination with all existing orthodontic bracket technologies. This proprietary technology (three issued patents) is licensed from the University of Illinois at Chicago and the company has engaged the leading researchers in this field including the inventor, Dr. Jeremy Mao, at Columbia University, Baylor College of Dentistry, and the University of Texas Health Sciences Center, Dental Branch. Together with these world-class partners, management will commercialize this innovation by 2009.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $82.9M
- Funding stage: Late Stage Venture
- Last round: Debt Financing (May 2019)
- Website: acceledent.comhome
- Phone: 832-631-1659
Industries & Categories
Biotechnology, Developer Platform, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/orthoaccel-technologies-22284 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.